Приказ основних података о документу

dc.creatorHorvat, J
dc.creatorBegović, D
dc.creatorStojić-Vukanić, Zorica
dc.creatorMilošević, D
dc.date.accessioned2019-09-02T10:49:36Z
dc.date.available2019-09-02T10:49:36Z
dc.date.issued1997
dc.identifier.issn0354-3447
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/145
dc.description.abstractThis report deals with the incidence and distribution of autoantibodies against well-defined human brain antigens S-100 and NSE in the development of neurologic and psychiatric syndromes. Serum samples from patients and controls were examined by means of an enzyme-linked immunosorbent assay (ELISA) for the presence of autoantibodies against human S-100 protein and NSE. The highest incidence of anti-S-100 and anti-NSE antibodies was in Parkinson's disease, Alzheimer's disease and senile dementia, and the lowest in schizophrenia and alcoholic syndrome. The frequency of anti-S-100 autoantibodies was higher than that of anti-NSE. In healthy individuals the incidence of antibrain antibodies was low. These results suggest the involvement of human autoimmune mechanism in the development of certain neuropsychiatric diseases.en
dc.publisherDruštvo medicinskih biohemičara Srbije i Crne Gore, Beograd i Univerzitet u Beogradu - Farmaceutski fakultet, Beograd
dc.rightsrestrictedAccess
dc.sourceJugoslovenska medicinska biohemija
dc.titleAutoantibodies against human brain S-100 protein and neuron specific enolase in neurological and psychiatric patientsen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractМилошевић, Д; Хорват, Ј; Беговић, Д; Стојић-Вуканић, Зорица;
dc.citation.volume16
dc.citation.issue4
dc.citation.spage217
dc.citation.epage219
dc.citation.other16(4): 217-219
dc.identifier.wos000071480700006
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_145
dc.type.versionpublishedVersion


Документи

ДатотекеВеличинаФорматПреглед

Уз овај запис нема датотека.

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу